knowledge -WSS

knowledge

author：entertainment 2025-10-02 22:27:18 - browse：73133

Is there a cure for allergies? Has the FDA become too flexible? And which drugs make you muscular?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Recorded live from from the STAT Breakthrough Summit East in New York City, we discuss some event highlights, including words from CRISPR pioneer Feng Zhang and Regeneron Pharmaceuticals head scientist George Yancopoulos. We also discuss the latest news in the life sciences, including a twist in the GLP-1 story, the cost of gene therapy, and, of course, pie.

For more on what we cover, here’s our full Summit coverage; here’s more on Medicare and GLP-1s; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Australia’s approach to dialysis celebrates life

WSS

Neuroscience startup Neumora files for IPO

Listen: Biogen's messy board & Laronde's data problem

4th of July breaks record for highest global temperature ever measured

Meta looks to target Twitter with a rival app called Threads

Radiation, mainstay of cancer treatment, begins a fade

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

entertainment

knowledge

focus

Sports medicine is finally prioritizing gender equality

Option Care buys Amedisys in $3.6 billion home care deal

Novavax promises a turnaround & Lilly roils the obesity market

Neuroscience startup Neumora files for IPO

In Memoriam: Notable people who died in 2023

Pfizer's Covid pill remains 89% effective in final analysis, company says

Walensky prepares to leave CDC — and Congress — behind

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Activists slam private health insurers over coverage restrictions

Departing Stanford president retracts two papers

focus

New case study details death in closely watched Alzhiemer's trial

Medicare explains how it will choose drugs for negotiation

Bacterial infection may be ‘key event’ in endometriosis, study says

Inside the fall of star MIT scientist David Sabatini

Medicare explains how it will choose drugs for negotiation

Radiation, mainstay of cancer treatment, begins a fade

hotspot

focus

Wikipedia

knowledge